Sweet targets: Sugar nucleotide biosynthesis inhibitors

Sanaz Ahmadipour; Jóhannes Reynisson; Robert A. Field; Gavin J. Miller

doi:10.4155/fmc-2021-0286

Sweet targets: Sugar nucleotide biosynthesis inhibitors

Sanaz Ahmadipour, Jóhannes Reynisson, Robert A. Field, Gavin J. Miller

School of Chemistry, Pharmacy and Pharmacology

Research output: Contribution to journal › Editorial › peer-review

3 Citations (Scopus)

Original language	English
Pages (from-to)	295-298
Number of pages	4
Journal	Future Medicinal Chemistry
Volume	14
Issue number	5
Early online date	7 Jan 2022
DOIs	https://doi.org/10.4155/fmc-2021-0286
Publication status	Published - Mar 2022

Access to Document

10.4155/fmc-2021-0286

Cite this

@article{f058da423b9e4ae79870f9fc7304e5d1,

title = "Sweet targets: Sugar nucleotide biosynthesis inhibitors",

author = "Sanaz Ahmadipour and J{\'o}hannes Reynisson and Field, {Robert A.} and Miller, {Gavin J.}",

note = "Funding Information: Financial support was received from UKRI, Engineering and Physical Sciences Research Council (EP/P000762/1) for the creation of this work. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.",

year = "2022",

month = mar,

doi = "10.4155/fmc-2021-0286",

language = "English",

volume = "14",

pages = "295--298",

journal = "Future Medicinal Chemistry",

issn = "1756-8919",

publisher = "Taylor and Francis",

number = "5",

}

TY - JOUR

T1 - Sweet targets: Sugar nucleotide biosynthesis inhibitors

AU - Ahmadipour, Sanaz

AU - Reynisson, Jóhannes

AU - Field, Robert A.

AU - Miller, Gavin J.

N1 - Funding Information: Financial support was received from UKRI, Engineering and Physical Sciences Research Council (EP/P000762/1) for the creation of this work. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.

PY - 2022/3

Y1 - 2022/3

UR - http://www.scopus.com/inward/record.url?scp=85125212069&partnerID=8YFLogxK

U2 - 10.4155/fmc-2021-0286

DO - 10.4155/fmc-2021-0286

M3 - Editorial

C2 - 34994583

AN - SCOPUS:85125212069

VL - 14

SP - 295

EP - 298

JO - Future Medicinal Chemistry

JF - Future Medicinal Chemistry

SN - 1756-8919

IS - 5

ER -

Sweet targets: Sugar nucleotide biosynthesis inhibitors

Access to Document

Other files and links

Cite this